Trials / Completed
CompletedNCT03611504
Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort
Hemospray Effectiveness and Predictors of Rebleeding in Patients With Gastrointestinal Hemorrhage: A Real-life Multicenter Cohort.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 261 (actual)
- Sponsor
- Hospital Universitario Ramon y Cajal · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an observational, retrospective, analytical, and multicenter study conducted at 17 hospitals. Our research aims to assess the effectiveness of Hemospray® in patients with gastrointestinal bleeding in clinical practice. Besides, we aim to detect predictors of treatment failure defined as unsuccessful immediate hemostasis or rebleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hemospray® | Hemospray® application |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2018-12-30
- Completion
- 2018-12-30
- First posted
- 2018-08-02
- Last updated
- 2019-02-21
Locations
1 site across 1 country: Spain
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03611504. Inclusion in this directory is not an endorsement.